2010 Annual Meeting | Botulinum Toxins: Practical Issues and Clinical Uses for Neurologists

Date Friday 04/16/10

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Virgilio Gerald H. Evidente, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to explain the mechanism of action of BoNT; describe the differences between various serotypes and brands; list the neurologic disorders in which BoNT is shown to be effective and the level of evidence that supports its use in these disorders; describe the anatomy of those regions commonly treated with BoNT; discuss the adverse effects that have been associated with BoNT injections into specific body regions; and apply the knowledge gained from this session to clinical cases.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
09:00 AM - 09:25 AM		Introduction to Botulinum Toxins Cynthia L. Comella, MD, FAAN
09:25 AM - 10:05 AM		BoNT for Hemifacial Spasm, Blepharospasm, and Oromandibular Dystonia Virgilio Gerald H. Evidente, MD, FAAN
10:05 AM - 10:20 AM		Break
10:20 AM - 11:00 AM		BoNT for Cervical Dystonia and Spasmodic Dysphonia Joseph Tsui, MBBS
11:00 AM - 11:40 AM		BoNT for Limb Spasticity and Dystonia Allison Brashear, MD, MBA, FAAN
11:40 AM - 12:10 PM		BoNT for Headache and Facial Pain Stephen D. Silberstein, MD, FAAN
12:10 PM - 12:30 PM		Case Presentations
12:30 PM - 12:45 PM		Questions and Answers

Faculty Disclosures
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Joseph Tsui, MBBS	No disclosure on file
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Virgilio Gerald H. Evidente, MD, FAAN	Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.

��ɫ��

��ɫ��